Memory deficits in the transgenic rat model of Huntington's disease

Behavioural Brain Research

Volumn 227, Issue 1, 2012, Pages 194-198

  Zeef, Dagmar H ^a,b,c   van Goethem, Nick P ^a,c   Vlamings, Rinske ^a,b,c   Schaper, Frédéric ^a,b,c   Jahanshahi, Ali ^a,b,c   Hescham, Sarah ^a,b,c   von Hörsten, Stephan ^d   Prickaerts, Jos ^a,c   Temel, Yasin ^a,b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c European Graduate School of Neuroscience   (Netherlands)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Huntington's disease; Memory deficits; Object location memory; Object recognition memory; Transgenic rat model

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPTH PERCEPTION; DISEASE COURSE; EXPERIMENTAL TEST; HUNTINGTON CHOREA; MALE; MEMORY DISORDER; NONHUMAN; OBJECT LOCATION TASK; OBJECT RECOGNITION TASK; PHENOTYPE; PRIORITY JOURNAL; RAT; RECOGNITION; SPATIAL MEMORY; TRANSGENIC MOUSE; VISUAL MEMORY;

AGE FACTORS; ANIMALS; DISCRIMINATION (PSYCHOLOGY); DISEASE MODELS, ANIMAL; HUMANS; HUNTINGTON DISEASE; MALE; MEMORY DISORDERS; MUTATION; NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; NUCLEAR PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; RECOGNITION (PSYCHOLOGY);

EID: 82655177738     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.11.009     Document Type: Article

References (42)

1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983. The Huntington's Disease Collaborative Research Group.
2. Vonsattel J.P., DiFiglia M. Huntington disease. J Neuropathol Exp Neurol 1998, 57:369-384.
3. Walker F.O. Huntington's disease. Lancet 2007, 369:218-228.
4. Kloppel S., Stonnington C.M., Petrovic P., Mobbs D., Tuscher O., Craufurd D., et al. Irritability in pre-clinical Huntington's disease. Neuropsychologia 2009, 48:549-557.
5. Lemiere J., Decruyenaere M., Evers-Kiebooms G., Vandenbussche E., Dom R. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation-a longitudinal follow-up study. J Neurol 2004, 251:935-942.
6. Lawrence A.D., Hodges J.R., Rosser A.E., Kershaw A., ffrench-Constant C., Rubinsztein D.C., et al. Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 1998, 121(Pt 7):1329-1341.
7. Snowden J., Craufurd D., Griffiths H., Thompson J., Neary D. Longitudinal evaluation of cognitive disorder in Huntington's disease. J Int Neuropsychol Soc 2001, 7:33-44.
8. Ayalon L., Doron R., Weiner I., Joel D. Amelioration of behavioral deficits in a rat model of Huntington's disease by an excitotoxic lesion to the globus pallidus. Exp Neurol 2004, 186:46-58.
9. Beal M.F., Ferrante R.J. Experimental therapeutics in transgenic mouse models of Huntington's disease. Nat Rev Neurosci 2004, 5:373-384.
10. Borlongan C.V., Koutouzis T.K., Sanberg P.R. 3-Nitropropionic acid animal model and Huntington's disease. Neurosci Biobehav Rev 1997, 21:289-293.
11. Ellison D.W., Beal M.F., Mazurek M.F., Malloy J.R., Bird E.D., Martin J.B. Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease. Brain 1987, 110(Pt 6):1657-1673.
12. Tabrizi S.J., Workman J., Hart P.E., Mangiarini L., Mahal A., Bates G., et al. Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse. Ann Neurol 2000, 47:80-86.
13. Hodgson J.G., Smith D.J., McCutcheon K., Koide H.B., Nishiyama K., Dinulos M.B., et al. Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype. Hum Mol Genet 1996, 5:1875-1885.
14. von Horsten S., Schmitt I., Nguyen H.P., Holzmann C., Schmidt T., Walther T., et al. Transgenic rat model of Huntington's disease. Hum Mol Genet 2003, 12:617-624.
15. Kantor O., Temel Y., Holzmann C., Raber K., Nguyen H.P., Cao C., et al. Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats. Neurobiol Dis 2006, 22:538-547.
16. Nguyen H.P., Kobbe P., Rahne H., Worpel T., Jager B., Stephan M., et al. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. Hum Mol Genet 2006, 15:3177-3194.
17. Petrasch-Parwez E., Nguyen H.P., Lobbecke-Schumacher M., Habbes H.W., Wieczorek S., Riess O., et al. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease. J Comp Neurol 2007, 501:716-730.
18. Faure A., Hohn S., Von Horsten S., Delatour B., Raber K., Le Blanc P., et al. Altered emotional and motivational processing in the transgenic rat model for Huntington's disease. Neurobiol Learn Mem 2011, 95:92-101.
19. Ciamei A., Morton A.J. Progressive imbalance in the interaction between spatial and procedural memory systems in the R6/2 mouse model of Huntington's disease. Neurobiol Learn Mem 2009, 92:417-428.
20. Grahn J.A., Parkinson J.A., Owen A.M. The role of the basal ganglia in learning and memory: neuropsychological studies. Behav Brain Res 2009, 199:53-60.
21. Ghiglieri V., Sgobio C., Costa C., Picconi B., Calabresi P. Striatum-hippocampus balance: from physiological behavior to interneuronal pathology. Prog Neurobiol 2011, 94:102-114.
22. Lawrence A.D., Watkins L.H., Sahakian B.J., Hodges J.R., Robbins T.W. Visual object and visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits. Brain 2000, 123(Pt 7):1349-1364.
23. Aggleton J.P., Vann S.D., Oswald C.J., Good M. Identifying cortical inputs to the rat hippocampus that subserve allocentric spatial processes: a simple problem with a complex answer. Hippocampus 2000, 10:466-474.
24. Mumby D.G., Piterkin P., Lecluse V., Lehmann H. Perirhinal cortex damage and anterograde object-recognition in rats after long retention intervals. Behav Brain Res 2007, 185:82-87.
25. Eichenbaum H., Yonelinas A.P., Ranganath C. The medial temporal lobe and recognition memory. Annu Rev Neurosci 2007, 30:123-152.
26. Abe H., Ishida Y., Nonaka H., Iwasaki T. Functional difference between rat perirhinal cortex and hippocampus in object and place discrimination tasks. Behav Brain Res 2009, 197:388-397.
27. Prickaerts J., Steinbusch H.W., Smits J.F., de Vente J. Possible role of nitric oxide-cyclic GMP pathway in object recognition memory: effects of 7-nitroindazole and zaprinast. Eur J Pharmacol 1997, 337:125-136.
28. Ennaceur A., Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav Brain Res 1988, 31:47-59.
29. Prickaerts J., Sik A., van Staveren W.C., Koopmans G., Steinbusch H.W., van der Staay F.J., et al. Phosphodiesterase type 5 inhibition improves early memory consolidation of object information. Neurochem Int 2004, 45:915-928.
30. Astur R.S., Klein R.L., Mumby D.G., Protz D.K., Sutherland R.J., Martin G.M. A role for olfaction in object recognition by normal and hippocampal-damaged rats. Neurobiol Learn Mem 2002, 78:186-191.
31. Rutten K., Van Donkelaar E.L., Ferrington L., Blokland A., Bollen E., Steinbusch H.W., et al. Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats. Neuropsychopharmacology 2009, 34:1914-1925.
32. Ho A.K., Sahakian B.J., Brown R.G., Barker R.A., Hodges J.R., Ane M.N., et al. Profile of cognitive progression in early Huntington's disease. Neurology 2003, 61:1702-1706.
33. Montoya A., Pelletier M., Menear M., Duplessis E., Richer F., Lepage M. Episodic memory impairment in Huntington's disease: a meta-analysis. Neuropsychologia 2006, 44:1984-1994.
34. Van Raamsdonk J.M., Pearson J., Slow E.J., Hossain S.M., Leavitt B.R., Hayden M.R. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J Neurosci 2005, 25:4169-4180.
35. Nance M.A., Myers R.H. Juvenile onset Huntington's disease-clinical and research perspectives. Ment Retard Dev Disabil Res Rev 2001, 7:153-157.
36. Cao C., Temel Y., Blokland A., Ozen H., Steinbusch H.W., Vlamings R., et al. Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic ratmodel. Behav Brain Res 2006, 170:257-261.
37. Petrasch-Parwez E., Habbes H.W., Weickert S., Lobbecke-Schumacher M., Striedinger K., Wieczorek S., et al. Fine-structural analysis and connexin expression in the retina of a transgenic model of Huntington's disease. J Comp Neurol 2004, 479:181-197.
38. Montoya A., Price B.H., Menear M., Lepage M. Brain imaging and cognitive dysfunctions in Huntington's disease. J Psychiatry Neurosci 2006, 31:21-29.
39. Giralt A., Rodrigo T., Martin E.D., Gonzalez J.R., Mila M., Cena V., et al. Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression. Neuroscience 2009, 158:1234-1250.
40. Murphy K.P., Carter R.J., Lione L.A., Mangiarini L., Mahal A., Bates G.P., et al. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J Neurosci 2000, 20:5115-5123.
41. Milnerwood A.J., Raymond L.A. Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load. J Physiol 2007, 585:817-831.
42. Simmons D.A., Rex C.S., Palmer L., Pandyarajan V., Fedulov V., Gall C.M., et al. Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice. Proc Natl Acad Sci USA 2009, 106:4906-4911.